Challenges for molecular profiling of chronic fatigue syndrome (Q36412667)

14 August 2017

1 reference

title

Challenges for molecular profiling of chronic fatigue syndrome (English)

1 reference

14 August 2017

1

Suzanne D Vernon

1 reference

14 August 2017

3

Eric Aslakson

1 reference

14 August 2017

Toni Whistler

2

1 reference

PubMed ID

16515400

14 August 2017

Mangalathu Rajeevan

series ordinal

4

1 reference

PubMed ID

16515400

14 August 2017

William C Reeves

series ordinal

5

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

2

1 reference

14 August 2017

211-218

1 reference

A community-based study of chronic fatigue syndrome

14 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The economic impact of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Epidemiology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Chronic fatigue syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The HPA axis and the genesis of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Chronic fatigue syndrome--a clinically empirical approach to its definition and study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Chronic fatigue in a population sample: definitions and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Development of the chronic fatigue syndrome in severely fatigued employees: predictors of outcome in the Maastricht cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Prevalence of chronic disabling fatigue in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Regional distribution of fatiguing illnesses in the United States: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case–control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Basic principles of immunological surveillance of the normal central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Assessment of normal variability in peripheral blood gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Individuality and variation in gene expression patterns in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Gene microarray analysis of multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Blood genomic expression profile for neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Exploration of neuroendocrine and immune gene expression in peripheral blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

A family history study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Is disabling fatigue in childhood influenced by genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Association between serotonin transporter gene polymorphism and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Association of medically unexplained fatigue with ACE insertion/deletion polymorphism in Gulf War veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Multiple-laboratory comparison of microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Unique genetic and environmental determinants of prolonged fatigue: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.2.211

21 January 2018

Identifiers

DOI

10.2217/14622416.7.2.211

1 reference

14 August 2017

1 reference

PubMed ID

16515400